SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

Dimethyl Sulfoxide Case: High-Purity Mass Production Challenges & Temperature-Controlled Moisture-Proof Formulation Optimization

Table of Content [Hide]

    HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services. It has established a service system framed as "1+2+3+4=1" and can supply DMSO sourced from multiple well-known original manufacturers.

    As a foreign trade enterprise with R&D capabilities, HiSiaddi frequently proposes DMSO formulation optimization schemes and application improvement recommendations through technological cooperation with manufacturers and precise market demand insight. Below is a case of HiSiaddi’s DMSO formulation optimization consulting service.

    For more formulation optimization consulting services, please contact HiSiaddi customer service.

    I. Client Background (Premium European Pharmaceutical Client)

    The client is the same Bavaria, Germany-based anti-tumor drug R&D and manufacturing enterprise featured in the prior DMSO customization case. It specializes in the mass production of targeted small-molecule API and cell therapy stock solutions, with all production lines adhering to EP Pharmacopoeia, GMP and EMA quality control standards, requiring an annual purchase of 108 tons of pharmaceutical-grade high-purity DMSO for two core production workflows: low-temperature drug synthesis and cell cryopreservation.

    After receiving and commissioning the first batch of HiSiaddi customized DMSO, full physical and chemical testing (purity, water content, heavy metals, endotoxin) of incoming raw materials fully complied with procurement agreement specifications. However, upon replacing the original BASF feedstock in mass production formulations, three consecutive manufacturing failures emerged: reduced synthetic reaction conversion rates, decreased cryopreserved cell viability, and viscous precipitates adhering to reactor vessel walls. Production line yield plummeted from 96% to 79%, delaying new drug mass production scheduling. The client’s internal R&D team spent 18 days repeatedly adjusting feed ratios, reaction temperatures and stirring parameters without resolving the issues, and formally commissioned HiSiaddi’s technical team to conduct full-process technical diagnostics and formulation optimization on-site.

    II. Three Core Technical Pain Points in Client Production

    Pain Point 1: Microphysical Property Differences in Raw Materials Lead to Insufficient Compatibility with Original Formulations

    Domestic high-purity DMSO exhibits subtle discrepancies in trace byproduct composition and molecular surface polarity compared with original European imported DMSO. The client retained formulations finalized for BASF feedstock, resulting in low compatibility between solubilizing aids, catalytic excipients and domestic DMSO. Catalytic active sites were coated by trace impurities, cutting coupling reaction conversion by 11%; solvent osmotic pressure imbalance within cell cryopreservation systems reduced target cell viability by 15%.

    Note: Raw materials fully passed national/pharmacopoeia standard testing upon delivery; microphysical differences cannot be detected via conventional raw material testing, representing a unique compatibility challenge exclusive to high-end pharmaceutical manufacturing.

    Pain Point 2: Irrational Feeding Process Triggers Solvent Agglomeration and Reactor Wall Fouling

    The client adopted a high-temperature one-time full-drum feeding process. While DMSO demonstrates excellent low-temperature solubility, its viscosity-temperature variation coefficient differs from imported alternatives. One-time bulk addition triggers localized solvent agglomeration; trace components decompose under high-temperature operating conditions, generating viscous byproducts that adhere to reactor walls. Daily production downtime is required for manual reactor cleaning, compressing effective production hours.

    Pain Point 3: Lack of Raw Material Pre-Warehousing Pretreatment Causes Trace Moisture Absorption to Disrupt Precision Reactions

    DMSO is highly hygroscopic. The client’s raw material warehouse dew point stood at -38°C (high-end pharmaceutical raw material standard requires ≤-55°C). No nitrogen protection was implemented during raw material opening and sampling, causing the surface layer of solid stock to absorb trace water vapor. Single-batch water content gradually rose from factory-discharged 0.01% to 0.038%. Trace moisture entering anhydrous synthesis systems induced hydrolysis side reactions, further lowering product yield.

    III. Step-by-Step Technical Solution Implemented by HiSiaddi (No Major Equipment Modifications or Core Formulation Overhauls, Low-Cost Deployment)

    HiSiaddi formed a special task force consisting of fine chemical solvent engineers, pharmaceutical synthesis technologists and application technical specialists, conducting full-chain fault investigation, solution debugging and on-site implementation guidance over a 7-day on-site residency.

    Step 1: Mechanism Traceability Testing to Identify Root Causes

    1. Collect full-component chromatographic data, surface tension, viscosity-temperature curves and trace impurity profiles for both original European DMSO and domestic customized DMSO;

    2. Conduct liquid phase and SEM physical & chemical analysis on failed finished products, confirming the root causes lie in formulation compatibility, feeding processes and raw material warehousing pretreatment, rather than substandard raw material quality.

    Step 2: Minor Formulation Tweaks to Improve System Compatibility

    While retaining the client’s original core raw material ratios unchanged:

    1. Synthesis Section: Fine-tune the proportion of supporting auxiliary agents and compound 0.2% dedicated solubilization improver to optimize interfacial compatibility between solvent and catalysts, fully unlocking catalytic activity;

    2. Cell Cryopreservation Section: Slightly adjust buffer salt ratios to balance solvent osmotic pressure and match the physical and chemical properties of domestic DMSO. After three rounds of small-scale trials, reaction conversion rates and cell viability recovered to baseline standards.

    Step 3: Optimize Staged Feeding & Temperature Control Processes to Eliminate Reactor Wall Deposition

    1. Revise feeding logic: Replace one-time high-temperature bulk feeding with low-temperature pre-dissolution and staged incremental feeding. First prime reactors with low-temperature solvent, then slowly add DMSO in batches for full dispersion;

    2. Adopt a gradient temperature rise curve to strictly control temperature rise rates within reaction ranges, avoiding solvent decomposition from localized overheating; adjust stirring speeds in stages to fundamentally eliminate viscous byproduct precipitation and adhesion.

    Step 4: Standardize Warehousing & Raw Material Pretreatment Operations to Block Trace Moisture Interference

    1. Warehouse Optimization: Guide the client to install nitrogen drying systems in raw material warehouses, lowering warehouse dew point from -38°C to ≤-58°C. Store full sealed pails; seal remaining raw materials with nitrogen after opening;

    2. Feeding Pretreatment: Add a low-temperature short vacuum drying step before feeding to remove trace water vapor adsorbed on raw material surfaces, with simple nitrogen protection maintained throughout feeding operations.

    Step 5: On-Site Training + Long-Term Technical Support

    1. Deliver specialized training to client production and R&D teams covering DMSO physical and chemical properties and supporting process adjustments, clarifying usage discrepancies between high-purity solvents sourced from different manufacturers;

    2. Establish monthly technical follow-up mechanisms with 7×24-hour technical response from HiSiaddi, conducting pre-sample compatibility testing in advance during new product formulation R&D in subsequent phases.

    IV. Implementation Outcomes

    1. Post-optimization continuous mass production verification across 5 batches: Synthesis conversion rates and cell viability returned to baseline levels, reactor wall adhesion issues were completely eliminated, and production line yield rebounded to 95.8%, restoring normal mass production scheduling;

    2. Client fully eliminated concerns over domestic raw material compatibility, with the full annual 108-ton DMSO order continuously fulfilled. HiSiaddi was simultaneously designated as the client’s fixed pre-screening service provider for raw materials in new product formulation development;

    3. Word-of-mouth from this technical service secured additional cooperation for pre-formulation testing of high-purity solvents within the same system (sulfolane, NMP).

    V. Case Value Summary

    1. Technical Service Value: High-end client procurement decisions rely not solely on paper test indicators; compatibility between raw materials and proprietary formulations & production line operating conditions represents core rigid demand. Moving beyond pure supply logic, HiSiaddi resolves production bottlenecks through application technical empowerment;

    2. Foreign Trade Differentiation Advantage: Distinct from pure supply trading companies, dual capabilities of front-end customization and back-end application technical support enable deep binding of high-end clients and build irreplaceable cooperation barriers;

    3. Supply-Demand Logic: Raw material switching across national borders inevitably creates physical property compatibility gaps. Proactive technical forecasting + rapid post-sales process optimization is the key to long-term client retention in high-end fine chemical foreign trade.

    For more formulation optimization consulting services, please contact HiSiaddi customer service.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All